このエントリーをはてなブックマークに追加
ID 20727
file
creator
Mitani, Yoshitsugu
Matsumura, Shunji
Yoshida, Kazuhiro
Noguchi, Tsuyoshi
Ito, Masanori
Kuniyasu, Hiroki
Kamata, Nobuyuki
subject
Reg IV
apoptosis
5-fluorouracil
serum tumor marker
SAGE
gastric cancer
NDC
Medical sciences
abstract
Regenerating gene family, member 4 (Reg IV), a secreted protein, is overexpressed in several cancers, including gastric cancer (GC). In the present study, we measured Reg IV levels in sera from patients with GC by enzyme-linked immunosorbent assay. We also examined the effect of forced Reg IV expression on the apoptotic susceptibility to 5-fluorouracil (5-FU). Forced expression of Reg IV inhibited 5-FU-induced apoptosis. Induction of Bcl-2 and dihydropyrimidine dehydrogenase was involved in inhibition of apoptosis. Among 36 GC patients treated with a combination chemotherapy of low-dose 5-FU and cisplatin, all 14 Reg IV-positive patients showed no change or disease progression. The serum Reg IV concentration was similar between healthy individuals (mean±s.e., 0.52±0.05 ng/ml) and patients with chronic-active gastritis (0.36±0.09 ng/ml). However, the serum Reg IV concentration in presurgical GC patients was significantly elevated (1.96±0.17 ng/ml), even at stage I. The diagnostic sensitivity of serum Reg IV (36.1%) was superior to that of serum carcinoembryonic antigen (11.5%) or carbohydrate antigen 19-9 (13.1%). These results indicate that expression of Reg IV is a marker for prediction of resistance to 5-FU-based chemotherapy in patients with GC. Serum Reg IV represents a novel biomarker for GC.
journal title
Oncogene
volume
Volume 26
issue
Issue 30
start page
4383
end page
4393
date of issued
2007
publisher
Nature Publishing Group
issn
0950-9232
ncid
publisher doi
pubmed id
language
eng
nii type
Journal Article
HU type
Journal Articles
DCMI type
text
format
application/pdf
text version
author
rights
Copyright (c) 2007 Nature Publishing Group.
relation url
department
Graduate School of Biomedical Science